Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
Public ClinicalTrials.gov record NCT02917031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 24 week, multicenter, randomized, double-blind, parallel group, placebo-controlled study to investigate the effects of saxagliptin and sitagliptin on cardiac dimensions and function in patients with type 2 diabetes (T2DM) mellitus and heart failure (HF).
Study identification
- NCT ID
- NCT02917031
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 348 participants
Conditions and interventions
Conditions
Interventions
- Saxagliptin Drug
- Sitagliptin Drug
- Placebo to match saxagliptin Drug
- Placebo to match sitagliptin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 10, 2017 (Actual)
- Primary completion
- Aug 23, 2019 (Actual)
- Completion
- Aug 23, 2019 (Actual)
- Last update posted
- Nov 8, 2021
2017 – 2019
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Torrance | California | 90502 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Miami | Florida | 33133 | — |
| Research Site | Ormond Beach | Florida | 32174 | — |
| Research Site | Chicago | Illinois | 60610 | — |
| Research Site | The Bronx | New York | 10455 | — |
| Research Site | The Bronx | New York | 10459 | — |
| Research Site | Sayre | Pennsylvania | 18840 | — |
| Research Site | Spartanburg | South Carolina | 29302 | — |
| Research Site | Houston | Texas | 77089 | — |
| Research Site | Milwaukee | Wisconsin | 64111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02917031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2021 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02917031 live on ClinicalTrials.gov.